Description
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Product Unit Size | Cost | Quantity | Stock |
---|
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Cas No. | 1202759-32-7 |
---|---|
Purity | ≥98% |
Formula | C26H22FN7O3 |
Formula Wt. | 499.50 |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
IUPAC Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
Synonym | CNX774 |
Solubility | DMSO 100 mg/mL (200.2 mM) Ethanol 2 mg/mL (4.0 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59. PMID: 23958373.
GLP-1/GIP receptor co-agonist
Selective inhibitor of c-Met.
Synthetic kahweol derivative.
VEGFR inhibitor.
Non-selective cannabinoid receptor agonist.
Endogenous calcitonin-family peptide, involved ...
Endogenous peptide hormone, GLP-1 fragment, inv...
Synthetic steroid hormone; ER antagonist.
Red-orange terpene pigment found in various pla...
Endogenous peptide hormone, counteracts insulin...
Extract containing catechins and flavonoids fou...
Non-depolarizing NMJ blocker; AChR antagonist.<...
Nonoxynol surfactant.
Pyrimidine derivative; kinesin Eg5 inhibitor.
Tyrosine kinase inhibitor.
Anthraquinone found in Rheum.
Cortisol derivative; glucocorticoid agonist.
Endogenous peptide hormone; GnRH agonist.
GABA-A α5/3/2 positive modulator.
Serine protease substrate/inhibitor.